Connection

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Search Results to Maurizio Zangari

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Zangari, Maurizio

One or more keywords matched the following items that are connected to Zangari, Maurizio

Item Type	Name
Academic Article	MDS-type abnormalities within myeloma signature karyotype (MM-MDS): only 13% 1-year survival despite tandem transplants.
Academic Article	Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression.
Academic Article	Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.
Academic Article	Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1.
Academic Article	Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities.
Academic Article	Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications.
Academic Article	Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.
Concept	Chromosome Aberrations
Academic Article	Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma.
Academic Article	Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan Transplants.
Academic Article	Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma.

Search Criteria

Chromosome Aberrations